Edition:
India

Deinove H1 operating loss widens to 4.8 million euros


Thursday, 28 Sep 2017 

Sept 28 (Reuters) - DEINOVE SA ::HALF-YEAR NET LOSS OF DEINOVE GROUP (COMPOSED OF DEINOVE AND DEINOBIOTICS) STANDS AT -EUR 3.3M.CASH POSITION: +EUR 6.6M AT JUNE 30, 2017 COMPARED TO +EUR 9.3M AT DECEMBER 31, 2016..H1 TOTAL OPERATING REVENUES EUR 140,000 VERSUS EUR 208,000 YEAR AGO.H1 OPERATING LOSS EUR 4.8 MILLION VERSUS LOSS OF EUR 4.2 MILLION YEAR AGO.CAROTENOIDS PROGRAM ENTERS PHASE 2 OF INDUSTRIALIZATION PROCESS.DEINOVE ASSISTED BY PROCESSIUM TO DEFINE AND IMPLEMENT INDUSTRIAL PRODUCTION PROCESS WITH VIEW TO MARKET FIRST BATCHES IN 2018.COLOR2B PROJECT: ON BASIS OF EFFICACY TESTS, ONE OR TWO STRAINS MAY BE SELECTED IN EARLY 2018 FOR INDUSTRIALIZATION STEP. 

Company Quote

1.128
0.006 +0.53%
19 Jul 2019